Last updated on July 2019

Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke

Brief description of study

This is a Phase II study to assess the safety and tolerability of DM199 in acute ischemic stroke patients. The study will be randomized, placebo controlled at multiple centers.

Clinical Study Identifier: NCT03290560

Find a site near you

Start Over

Royal Adelaide Hospital

Adelaide, Australia
  Connect »